Ocular Therapeutix Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:0OT Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
25 Nov 24	Sell€15,573	Sanjay Nayak	Individual	1,814	€8.59
25 Nov 24	Sell€177,737	Pravin Dugel	Individual	20,680	€8.59
25 Nov 24	Sell€24,899	Peter Kaiser	Individual	2,897	€8.59
25 Nov 24	Sell€25,337	Jeffrey Heier	Individual	2,948	€8.59
23 Aug 24	Sell€14,763	Sanjay Nayak	Individual	1,832	€8.06
23 Aug 24	Sell€168,261	Pravin Dugel	Individual	20,880	€8.06
23 May 24	Sell€12,270	Sanjay Nayak	Individual	2,274	€5.40
23 May 24	Sell€115,686	Pravin Dugel	Individual	21,626	€5.35
26 Feb 24	Buy€6,452,600	Summer Road LLC	Company	930,851	€6.93
05 Feb 24	Sell€88,997	Antony Mattessich	Individual	19,642	€4.53
05 Feb 24	Sell€28,146	Donald Notman	Individual	6,212	€4.53
05 Feb 24	Sell€28,754	Rabia Ozden	Individual	6,346	€4.53
05 Feb 24	Sell€27,317	Philip Strassurger	Individual	6,029	€4.53
05 Feb 24	Sell€26,778	Christopher White	Individual	5,910	€4.53
31 Jan 24	Sell€83,666	Antony Mattessich	Individual	18,338	€4.56
31 Jan 24	Sell€31,166	Philip Strassurger	Individual	6,831	€4.56
31 Jan 24	Sell€29,350	Donald Notman	Individual	6,433	€4.56
31 Jan 24	Sell€23,483	Christopher White	Individual	5,147	€4.56
31 Jan 24	Sell€35,423	Rabia Ozden	Individual	7,764	€4.56

Insider Trading Volume

Insider Buying: 0OT insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0OT?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,191,116	0.758%
Hedge Funds	8,060,000	5.13%
General Public	15,436,961	9.82%
VC/PE Firms	25,483,922	16.2%
Institutions	107,045,428	68.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 42.6%.

Top Shareholders

Top 25 shareholders own 75.74% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.16%	Summer Road LLC	14,398,193	€124.7m	-3.27%	98.78%
8.12%	VR Adviser, LLC	12,762,462	€110.5m	0%	5.74%
8.09%	Deep Track Capital, LP	12,721,460	€110.1m	0%	3.58%
7.22%	BlackRock, Inc.	11,354,164	€98.3m	-1.44%	no data
5.33%	The Vanguard Group, Inc.	8,384,183	€72.6m	-2.65%	no data
5.13%	Avoro Capital Advisors LLC	8,060,000	€69.8m	0%	0.99%
3.38%	TCG Crossover Management, LLC	5,319,148	€46.1m	0%	4.28%
3.2%	Opaleye Management Inc.	5,025,000	€43.5m	-5.32%	7.67%
2.71%	Citadel Advisors LLC	4,259,838	€36.9m	5.08%	0.04%
2.39%	Adage Capital Management, L.P.	3,750,000	€32.5m	1.49%	0.06%
2.23%	Logos Global Management, L.P.	3,500,000	€30.3m	-32%	3.95%
2.21%	State Street Global Advisors, Inc.	3,476,292	€30.1m	-11.3%	no data
2.11%	Perceptive Advisors LLC	3,324,468	€28.8m	0%	0.7%
2.08%	Geode Capital Management, LLC	3,271,207	€28.3m	-5.24%	no data
1.8%	Assenagon Asset Management S.A.	2,825,756	€24.5m	20,500%	0.04%
1.65%	Deltec Asset Management LLC	2,600,073	€22.5m	0.38%	4.2%
1.54%	Octagon Capital Advisors LP	2,425,000	€21.0m	0%	3.44%
1.42%	Braidwell LP	2,239,770	€19.4m	36.3%	0.87%
1.3%	Point72 Asset Management, L.P.	2,040,620	€17.7m	-24.6%	0.05%
0.99%	Morgan Stanley, Investment Banking and Brokerage Investments	1,562,320	€13.5m	40.9%	no data
0.79%	Northern Trust Global Investments	1,246,697	€10.8m	15.5%	no data
0.76%	Acuta Capital Partners, LLC	1,190,071	€10.3m	-57.1%	9.54%
0.74%	Franklin Resources, Inc.	1,170,047	€10.1m	0%	no data
0.71%	Charles Schwab Investment Management, Inc.	1,110,460	€9.6m	147%	no data
0.67%	Artisan Partners Limited Partnership	1,056,092	€9.1m	0%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/10 07:39
End of Day Share Price	2025/01/10 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ocular Therapeutix, Inc. is covered by 21 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Colleen Kusy	Baird
Anita Dushyanth	Berenberg
Tazeen Ahmad	BofA Global Research